Unsubstantiated drug price hikes cost $1.67B last year

Pharmaceutical companies continue to increase the prices of their most profitable drugs despite minimal year-over-year improvements, according to a new report. Seven of the top 10 drugs that inflated U.S. healthcare spending in 2020 due to price increases did not offer substantial clinical benefits, the Institute for Clinical and Economic Review’s analysis found.

Read the source article at Home | Modern Healthcare
2021-11-16 22:27:49